Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NAYA Biosciences Inc. Com...

    NASDAQ: IVF · Real-Time Price · USD
    1.30
    -0.12 (-8.45%)
    At close: Jun 13, 2025, 3:59 PM
    1.32
    1.54%
    After-hours: Jun 13, 2025, 05:49 PM EDT

    NAYA Biosciences Common Stock Statistics

    Share Statistics

    NAYA Biosciences Common Stock has 2.15M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 2.15M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 905

    FTD / Avg. Volume

    n/a
    		 0.04%

    Short Selling Information

    The latest short interest is 31.27K, so 1.46% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 31.27K

    Short % of Shares Out

    n/a
    		 1.46%

    Short % of Float

    n/a
    		 1.46%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.06 and the forward PE ratio is -1.45. NAYA Biosciences Common Stock's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.06

    Forward PE

    n/a
    		 -1.45

    PS Ratio

    n/a
    		 0.09

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 0.04

    P/FCF Ratio

    n/a
    		 -0.18

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for NAYA Biosciences Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.07, with a Debt / Equity ratio of 0.78.

    Current Ratio

    n/a
    		 0.07

    Quick Ratio

    n/a
    		 0.06

    Debt / Equity

    n/a
    		 0.78

    Debt / EBITDA

    n/a
    		 -1.39

    Debt / FCF

    n/a
    		 -3.13

    Interest Coverage

    n/a
    		 -7.69

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $197,939.39

    Profits Per Employee

    n/a
    		 $-275,631.45

    Employee Count

    n/a
    		 33

    Asset Turnover

    n/a
    		 0.14

    Inventory Turnover

    n/a
    		 16.64

    Taxes

    Income Tax

    n/a
    		 -22.91K

    Effective Tax Rate

    n/a
    		 0.25%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0, so NAYA Biosciences Common Stock's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 n/a

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 33.68

    Average Volume (20 Days)

    n/a
    		 2,233,083

    Income Statement

    In the last 12 months, NAYA Biosciences Common Stock had revenue of 6.53M and earned -9.1M in profits. Earnings per share was -30.19.

    Revenue

    n/a
    		 6.53M

    Gross Profit

    n/a
    		 2.87M

    Operating Income

    n/a
    		 -8.13M

    Net Income

    n/a
    		 -9.1M

    EBITDA

    n/a
    		 -7.14M

    EBIT

    n/a
    		 -8.06M

    Earnings Per Share (EPS)

    n/a
    		 -30.19
    Full Income Statement

    Balance Sheet

    The company has 741.4K in cash and 9.9M in debt, giving a net cash position of -9.15M.

    Cash & Cash Equivalents

    n/a
    		 741.4K

    Total Debt

    n/a
    		 9.9M

    Net Cash

    n/a
    		 -9.15M

    Retained Earnings

    n/a
    		 -67.16M

    Total Assets

    n/a
    		 46.45M

    Working Capital

    n/a
    		 -16.61M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -2.97M and capital expenditures -183.7K, giving a free cash flow of -3.16M.

    Operating Cash Flow

    n/a
    		 -2.97M

    Capital Expenditures

    n/a
    		 -183.7K

    Free Cash Flow

    n/a
    		 -3.16M

    FCF Per Share

    n/a
    		 -10.2
    Full Cash Flow Statement

    Margins

    Gross margin is 44%, with operating and profit margins of -124.4% and -139.25%.

    Gross Margin

    n/a
    		 44%

    Operating Margin

    n/a
    		 -124.4%

    Pretax Margin

    n/a
    		 -139.6%

    Profit Margin

    n/a
    		 -139.25%

    EBITDA Margin

    n/a
    		 -109.35%

    EBIT Margin

    n/a
    		 -124.4%

    FCF Margin

    n/a
    		 -48.35%

    Dividends & Yields

    IVF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for IVF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2.82

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist